DBV Technologies (DBVT) Other financing activities (2016 - 2021)
DBV Technologies (DBVT) reported Other financing activities of $6000.0 for Q4 2021, up 150.0% year-over-year from $2400.0 in Q4 2020, and up 250.0% on a QoQ basis from -$4000.0 in Q3 2021.
DBV Technologies (DBVT) has 5 years of Other financing activities data on file, last reported at $6000.0 in Q4 2021.
- Quarterly Other financing activities rose 150.0% year-over-year to $6000.0 in Q4 2021, while the trailing twelve-month figure through Sep 2022 was $6000.0 (up 118.18% YoY) and the FY2021 annual result came in at -$15000.0, up 58.33% from the prior year.
- Other financing activities improved to $6000.0 in Q4 2021 per DBVT's latest filing, from -$4000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $88551.0 in Q4 2019 and bottomed at -$167490.6 in Q3 2018.
- The 4-year median for Other financing activities is -$12000.0 (2020), against an average of -$46353.1.
- The widest annual swing landed in 2019, when Other financing activities jumped 153.88%; it then slumped 142.86% in 2021.
- Tracing DBVT's Other financing activities over 4 years: stood at -$164361.1 in 2018, then surged by 153.88% to $88551.0 in 2019, then tumbled by 113.55% to -$12000.0 in 2020, then soared by 150.0% to $6000.0 in 2021.
- Per Business Quant, the three latest DBVT Other financing activities figures stand at $6000.0 (Q4 2021), -$4000.0 (Q3 2021), and -$17000.0 (Q1 2021).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | DBV Technologies | 8.00 Bn | 7.77 Bn | -3.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 6,000.00 |
| Dec 31, 2021 | 6,000.00 |
| Sep 30, 2021 | -4,000.00 |
| Sep 30, 2021 | -4,000.00 |
| Mar 31, 2021 | -17,000.00 |
| Mar 31, 2021 | -17,000.00 |
| Dec 31, 2020 | -12,000.00 |
| Dec 31, 2020 | -12,000.00 |
| Sep 30, 2020 | -5,000.00 |
| Sep 30, 2020 | -5,000.00 |
| Jun 30, 2020 | -12,000.00 |
| Jun 30, 2020 | -12,000.00 |
| Mar 31, 2020 | -7,000.00 |
| Mar 31, 2020 | -7,000.00 |
| Dec 31, 2019 | 88,551.01 |
| Dec 31, 2019 | 88,551.01 |
| Sep 30, 2019 | -116,836.65 |
| Sep 30, 2019 | -116,836.65 |
| Jun 30, 2019 | -30,338.26 |
| Jun 30, 2019 | -30,338.26 |
| Dec 31, 2018 | -164,361.09 |
| Dec 31, 2018 | -164,361.09 |
| Sep 30, 2018 | -167,490.60 |
| Sep 30, 2018 | -167,490.60 |
| Jun 30, 2018 | -161,115.00 |
| Jun 30, 2018 | -161,115.00 |
| Dec 31, 2016 | -22,674.21 |
| Dec 31, 2016 | -22,674.21 |